Brief: Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
July 31 (Reuters) - FRESENIUS MEDICAL CARE AG FMEG.DE: FRESENIUS MEDICAL CARE'S THIRD-PARTY CLINICAL RESEARCH ORGANIZATION FRENOVA ANNOUNCES STRATEGIC COLLABORATION ADVANCING GENOMICS-DRIVEN, PRECISION KIDNEY DISEASE CARE Source text: ID:nPnRntzka Further company coverage: AZTA.O (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Fresenius Medical Care AG
See all newsFMC seen down as Fresenius cuts stake to 20%
Germany's Fresenius cuts FMC stake to 20%
Brief: Fresenius Investment In Fresenius Medical Care Reduced From Approximately 25% To Approximately 20% Of Issued Share Capital
Brief: Fresenius Medical Care AG ABB Orders Below Eur 39.00 Per Share, Says Book Runner
Brief: Bookrunner Says Fresenius Medical ABB C. 13.4 Mln Shares, Books Are Closed